Go back
HSA-MIR-429
| Id | 207 |
| Name | hsa-mir-429 |
| Chromosome | chr1 (NC_000001) |
| PrecStart | 1169005 |
| PrecEnd | 1169087 |
| Length | 83 |
| Strand | forward |
| Is at most 5 Mbp to chromosome end | Yes |
| Is at most 5 Mbp to chromosome centromere | Yes |
| Protein host gene | No |
| Intronic | No |
| Clustered | Yes |
| Probability | 0.4753970557233119 |
| ChrEnd | 1 |
| ChrCentr | 1 |
DOI | Detected in | In presence of | Expression profile |
|---|---|---|---|
| https://doi.org/10.1016/j.biopha.2020.109889 | Li Shuai, Hou Xinfang, Wu Chen, Han Lili, Li Qian, Wang Jufeng, Luo Suxia (2020). MiR-645 promotes invasiveness, metastasis and tumor growth in colorectal cancer by targeting EFNA5. Biomedicine & Pharmacotherapy, 125(), 109889. | colorectal cancer | up |
| https://doi.org/10.1155/2013/804128 | Huang Xiao-Ying, Yao Jin-Guang, Huang Hong-Dong, Wang Chao, Ma Yun, Xia Qiang, Long Xi-Dai (2013). MicroRNA-429 Modulates Hepatocellular Carcinoma Prognosis and Tumorigenesis. Gastroenterology Research and Practice, 2013(), 1-10. | hepatocellular carcinoma | up |
| https://doi.org/10.1136/gutjnl-2013-305715 | Li Liang, Tang Jing, Zhang Baohua, Yang Wen, LiuGao Miyang, Wang Ruoyu, Tan Yexiong, Fan Jianling, Chang Yanxin, Fu Jing, Jiang Feng, Chen Caiyang, Yang Yingcheng, Gu Jin, Wu Dingming, Guo Linna, Cao Dan, Li Hengyu, Cao Guangwen, Wu Mengchao, Zhang Michael Q, Chen Lei, Wang Hongyang (2014). Epigenetic modification of MiR-429 promotes liver tumour-initiating cell properties by targeting Rb binding protein 4. Gut, 64(1), 156-167. | hepatocellular carcinoma | up |
| https://doi.org/10.1371/journal.pone.0013176 | Elson-Schwab Ilan, Lorentzen Anna, Marshall Christopher J. (2010). MicroRNA-200 Family Members Differentially Regulate Morphological Plasticity and Mode of Melanoma Cell Invasion. PLoS ONE, 5(10), e13176. | malignant melanoma | up |
| https://doi.org/10.18632/oncotarget.19878 | Yang Jiangeng, Liu Yuchen, He Anbang, Liu Yuhan, Wu Jianting, Liao Xinhui, Lv Zhaojie, Wang Feng, Mei Hongbing (2017). Hsa-miR-429 promotes bladder cancer cell proliferation via inhibiting CDKN2B. Oncotarget, 8(40), 68721-68729. | bladder cancer | up |
| https://doi.org/10.1038/nm.2401 | Korpal Manav, Ell Brian J, Buffa Francesca M, Ibrahim Toni, Blanco Mario A, Celià-Terrassa Toni, Mercatali Laura, Khan Zia, Goodarzi Hani, Hua Yuling, Wei Yong, Hu Guohong, Garcia Benjamin A, Ragoussis Jiannis, Amadori Dino, Harris Adrian L, Kang Yibin (2011). Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization. Nature Medicine, 17(9), 1101-1108. | breast cancer | up |
| https://doi.org/10.3802/jgo.2023.34.s1.e03 | Lee Kyungjun, Park Sung Taek (2023). miR-429 mediates tumor growth and metastasis by targeting ROR1 in endometrial cancer. Proceedings of the 38th Annual Meeting of Korean Society of Gynecologic Oncology, (), E03. | colorectal cancer | up |
| https://doi.org/10.2147/ott.s104729 | Wen Bin, Huang Chao, Wu Liyun, Liu Hong (2016). Effect of evodiamine and berberine on miR-429 as an oncogene in human colorectal cancer. OncoTargets and Therapy, Volume 9(), 4121-4127. | colorectal cancer | up |
| https://doi.org/10.1016/j.canlet.2012.10.019 | Li Juan, Du Lutao, Yang Yongmei, Wang Chuanxin, Liu Hui, Wang Lili, Zhang Xin, Li Wei, Zheng Guixi, Dong Zhaogang (2013). MiR-429 is an independent prognostic factor in colorectal cancer and exerts its anti-apoptotic function by targeting SOX2. Cancer Letters, 329(1), 84-90. | colorectal cancer | up |
| https://doi.org/10.3892/ol.2015.3179 | CHEN ZHAOFENG, LIU XIAOGUANG, HU ZENAN, WANG YUPING, LIU MIN, LIU XIAOJUN, LI HAILONG, JI RUI, GUO QINHONG, ZHOU YONGNING (2015). Identification and characterization of tumor suppressor and oncogenic miRNAs in gastric cancer. Oncology Letters, 10(1), 329-336. | gastric cancer | up |